GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 96 filers reported holding GENERATION BIO CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,863,991 | -28.7% | 2,338,784 | +3.5% | 0.00% | – |
| Q2 2023 | $12,425,924 | +28.9% | 2,259,259 | +0.7% | 0.00% | – |
| Q1 2023 | $9,643,396 | +10.0% | 2,242,650 | +0.5% | 0.00% | – |
| Q4 2022 | $8,769,791 | -25.6% | 2,231,499 | +0.6% | 0.00% | – |
| Q3 2022 | $11,780,000 | -18.8% | 2,218,522 | +0.4% | 0.00% | – |
| Q2 2022 | $14,500,000 | -44.3% | 2,210,309 | -37.7% | 0.00% | -100.0% |
| Q1 2022 | $26,051,000 | +2.4% | 3,549,177 | -1.3% | 0.00% | 0.0% |
| Q4 2021 | $25,449,000 | -71.4% | 3,594,461 | +1.2% | 0.00% | -50.0% |
| Q3 2021 | $89,026,000 | +2.6% | 3,551,075 | +10.1% | 0.00% | 0.0% |
| Q2 2021 | $86,761,000 | +3.9% | 3,225,326 | +9.9% | 0.00% | 0.0% |
| Q1 2021 | $83,541,000 | +218.1% | 2,935,382 | +216.8% | 0.00% | +100.0% |
| Q4 2020 | $26,265,000 | +0.2% | 926,446 | +9.2% | 0.00% | 0.0% |
| Q3 2020 | $26,213,000 | +2396.5% | 848,047 | +1596.1% | 0.00% | – |
| Q2 2020 | $1,050,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |